Consistent with this, a multicenter prospective study found a two-fold increase in serum myostatin levels significantly predicted a higher risk of HCC development in patients with alcoholic cirrhosis (Kim et al. 2020). The gene discussed is MSTN; the disease is hepatocellular carcinoma.